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Abstract
We conducted a comprehensive study of copy number variants (CNVs) well-tagged by SNPs (r
2$0.8) by analyzing their
effect on gene expression and their association with disease susceptibility and other complex human traits. We tested
whether these CNVs were more likely to be functional than frequency-matched SNPs as trait-associated loci or as expression
quantitative trait loci (eQTLs) influencing phenotype by altering gene regulation. Our study found that CNV–tagging SNPs
are significantly enriched for cis eQTLs; furthermore, we observed that trait associations from the NHGRI catalog show an
overrepresentation of SNPs tagging CNVs relative to frequency-matched SNPs. We found that these SNPs tagging CNVs are
more likely to affect multiple expression traits than frequency-matched variants. Given these findings on the functional
relevance of CNVs, we created an online resource of expression-associated CNVs (eCNVs) using the most comprehensive
population-based map of CNVs to inform future studies of complex traits. Although previous studies of common CNVs that
can be typed on existing platforms and/or interrogated by SNPs in genome-wide association studies concluded that such
CNVs appear unlikely to have a major role in the genetic basis of several complex diseases examined, our findings indicate
that it would be premature to dismiss the possibility that even common CNVs may contribute to complex phenotypes and
at least some common diseases.
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Introduction
Although genome wide association studies (GWAS) have
considerably advanced our knowledge of the genetics of complex
traits, they fail to account for the bulk of the overall heritability [1].
Structural variation, including copy number variants (CNVs), may
account for some of the missing heritability, but a comprehensive
study of the contribution of these variants to complex traits
genetics is generally lacking. One of the main challenges of
integrating CNVs into GWAS is the reliability of their assay, but
improvements in genotyping platforms and the development of
algorithms for the analysis of CNVs increasingly facilitate the
investigation of the role of CNVs in disease susceptibility [2].
Given the effect of adjacent CNVs on SNP intensity data, early
SNP arrays were designed with the consequence that assays from
many CNV loci were excluded, but a newer generation of arrays
have been implemented that combine SNP assays and copy
number probes optimized for copy-number measurement for
target regions of known CNVs [3]. New algorithms are also
facilitating higher resolution maps of common CNVs (those that
segregate at an allele frequency .5%).
Partly due to these technological and analytic developments, the
search for links between CNVs and disease susceptibility has been
actively pursued in recent years. Structural variation has of course
long been known to influence such Mendelian disorders as
Williams-Beuren syndrome or Charcot-Marie Tooth neuropathy
Type 1A, but more recently there has been widespread interest in
the study of CNVs as mediators of more common complex
diseases. The contribution of structural variation to certain
neurodevelopmental disorders such as schizophrenia and autism
spectrum disorder has been investigated by recent studies of de novo
copy number variation [4]. A common 20 kb deletion upstream of
IRGM in perfect linkage disequilibrium (r
2=1.0) with the SNP
most strongly associated with Crohn’s disease in the region has
recently been shown to alter IRGM regulation, which in turn is
known to affect autophagy, consistent with the deletion polymor-
phism being the causal allele [5]. Similarly, a 45 kb deletion
polymorphism in NEGR1 has been shown to be the likely causal
variant for the reproducible association with body mass index in
humans, demonstrating a neuronal influence on body weight
regulation [6]. These discoveries and similar developments suggest
that the interpretation of known disease associations continues to
be fraught with challenges, as CNVs may be in linkage
disequilibrium (LD) with associated variants, and that the
identification of causal variants requires an approach that
considers both SNPs and CNVs at associated loci.
The recent release [7] of a reference map of human CNVs in
the HapMap populations promises to shed light on the role of
these variants in disease pathogenesis. On the other hand, a recent
comprehensive study [8] involving 16,000 cases of eight common
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likely to make a relatively minor contribution to disease
susceptibility. In the present study, we approached the investiga-
tion of this important topic by exploring evidence of enrichment of
CNVs among trait-associated loci in disease susceptibility and in
disease classes, as represented by the NHGRI catalog of
reproducible associations from genome-wide association scans
[9], for certain classes of CNVs, and by conducting a
comprehensive functional characterization of CNVs as expression
quantitative trait loci (eQTLs). The former seeks to evaluate the
genetic information contained in CNVs in regard to disease risk
and other complex traits; the latter assesses the functional impact
of CNVs on the transcriptome, through which they may
contribute to or cause disease phenotypes and other complex
traits [10].
Results
Tagged CNVs (tCNVs) are enriched for eQTLs and
cis-acting eQTLs
Table 1 summarizes the CNVs included in our study. Because
of the ease with which SNPs can be utilized in enrichment studies
appropriately conditioned on minor allele frequency, we utilized
tCNVs (CNVs tagged by SNPs) for many of these studies, but did
not otherwise consider them to be a special class of CNVs.
At an expression p value threshold of 10
24, tCNVs from the
recently released study (N=3,432) of CNVs in 16,000 cases and
3,000 controls [8] were evaluated for their effect on gene
expression. We first considered tCNVs that are tagged at
r
2$0.80. The tag SNPs for these CNVs enable SNP-based
analyses and simulation studies. We identified 1,714 such SNPs
tagging CNVs (corresponding to 1,761 tCNVs), of which 532 are
eQTLs at this threshold; collectively, these SNPs tagging CNVs
were found to target 2,215 distinct transcripts. Restricting our
focus to eQTLs that regulate transcript levels in cis (defined as
within 4 MB of target transcript), we observed a highly significant
cis eQTL enrichment (p,0.001) from a simulation procedure
(N=1000) used to empirically generate the null distribution using
randomly generated sets of variants of the same set size and
matching minor allele frequency distribution as the SNPs tagging
CNVs (see Materials and Methods). These SNPs tagging CNVs
are significantly more likely to be associated with altered
expression of genes in their vicinity than frequency-matched SNPs
(see Figure 1). Specifically, 24 such SNPs tagging CNVs are acting
in cis, whereas the expected count is 10.7 (SD=3.2). On the other
hand, the observed count of trans-acting eQTLs is 508 while
expected count is 488.9 (SD=17.6).
We identified 621 SNPs tagging CNVs corresponding to 626
tCNVs that are perfectly tagged (r
2=1.0). Of these 621, 185
predict the expression of at least one transcript, whereas, based on
simulations, the expected count is 166.5 (SD=9.9). This
observation implies a statistically significant (p=0.024) enrichment
for eQTLs among this class of CNVs. Restricting our focus to
eQTLs that regulate transcript levels locally, we observed 10 such
cis-acting tCNVs. This observed count is, as before, a significant
enrichment (p,0.001) for cis-acting regulators compared with
expected count (see Materials and Methods) of 3.5 (SD=1.9) (see
Figure S1).
To determine whether our observations are dependent on the p
value threshold used to define an eQTL, we explored evidence of
eQTL enrichment among the tCNVs (r
2$0.80) at p,10
26.
Simulations yielded an expected eQTL count of 19.7 (SD=4.5)
whereas observed count is 28, yielding a statistically significant
enrichment (p=0.036). Expected cis-acting eQTL count is 1.9
(SD=1.4) while observed count is 8. These findings demonstrate
that the observed enrichment holds robustly at lower expression
thresholds. There are 2.5 times as many trans eQTLs as cis eQTLs
among the tCNVs at this threshold.
Using Gene Ontology (GO) enrichment [11], we found the
target genes of these expression associated CNVs (eCNVs) to show
a highly significant overrepresentation for certain biological
processes including immune response (p=2.3e-4, adjusted p-value
0.034) and regulation of apoptosis (p=8e-6, adjusted p-value
0.015). Relative to other genic CNVs, the observation on the
enrichment of the target genes of eCNVs for response to stimuli
continues to hold (p=9.9e-3, adjusted p-value 0.05).
tCNVs are enriched for eQTL hotspots
Notably, we identified 22 tCNVs (r
2=1) that predict the
transcript level of 10 or more genes. These CNVs are regulating
the expression of distal transcripts. By performing simulations on
frequency-matched SNPs as the tCNVs, we observed an enrich-
ment (expected count=14.7, SD=3.8) for CNVs controlling the
expression of 10 or more, often distal, transcripts (See Figure S1).




2$0.80) in WTCCC study 1761
Remaining CNVs (r
2,0.80) in WTCCC study 1671
Non-WTCCC CNVs assayed in HapMap cell lines included in this study 1503
Three classes of CNVs were investigated. The WTCCC CNVs were divided into
two groups, according to whether they were tagged (r
2$0.80) by a local (i.e.,
within 1 MB) SNP from imputed WTCCC1 data and genotyped WTCCC2 data
from both the Affymetrix and Illumina arrays (see http://www.wtccc.org.uk/
wtcccplus_cnv/masterCNVlist.final.README.txt). The third group contains CNVs
assayed in HapMap LCLs (Conrad et al.) that were determined to be different
from those in the WTCCC set.
doi:10.1371/journal.pgen.1001292.t001
Author Summary
Despite the large number of SNPs found to be reproduc-
ibly associated with complex diseases, they collectively
account for only a small proportion of the overall
heritability to such traits. CNVs have thus been proposed
to explain some of the missing heritability and to alter
disease susceptibility. However, a recent study of the
genetics of 8 common diseases involving 16,000 cases and
3,000 controls failed to identify any novel CNVs associated
with disease and concluded that CNVs are unlikely to play
a major role in their etiology. Studies we report here show
that we must be careful not to dismiss the possibility that
CNVs may indeed underlie some of the observed
associations with complex disease. Our findings show that
well-tagged CNVs are disproportionately more likely to be
eQTLs, as well as cis-eQTLs, than frequency-matched SNPs;
furthermore, reproducible trait associations, as represent-
ed in the NHGRI catalog, are enriched for well-tagged
CNVs than frequency-matched SNPs. Because of these
findingson the strong functional relevanceof theseCNVs, we
created a database (available at http://www.scandb.org/)
of expression associated CNVs to supplement our earlier
studies of SNP eQTLs and to contribute to future studies of
the genetics of complex traits.
CNVs As Trait-Associated Variants and As eQTLs
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and CNVR1045.1 (chrom2:165722938–165725072) that predict the
expression of at least 100 transcripts. CNVR4596.1 does not contain
any genes; on the other hand, CNVR1045.1 overlaps with SCN3A.
Additional CNVs CNVR3307.1 (chrom7:17780194–17781249),
CNVR3500.1 (chrom7:97233946–97240537), and CNVR7062.1
(chrom17:27130696–27131638) predict the expression of at least
50transcripts.TheCNVregionCNVR3307.1containsseveralSNPs
(e.g., rs2723520, rs1404418,a n drs1404419) in strong LD, which
individually predict the expression of more than 80 transcripts.
We identified a CNV (CNVR2845.27 at chrom6:32710664–
32743652) in perfect LD with the replicated type 1 diabetes SNP
rs9272346 predicting the expression of at least 20 transcripts,
mostly in the HLA region; a CNV (CNVR2845.40 at
chrom6:32735154–32737954) is tagged (r
2=0.95) by the same
type 1 diabetes SNP. A tCNV CNVR2845.46 is also in strong LD
(r
2=0.93) with a replicated multiple sclerosis SNP rs3135388 and
predicts the expression of 20 transcripts (of which the largest
expression association p value is ,10
233).
CNVs harbor a high proportion of regulatory SNPs
Since the deletion/duplication of multiple regulatory SNPs may
result in aberrant transcription or disease, we evaluated the
presence of SNP eQTLs within CNVs. We identified 33 CNVs
harboring 50 or more SNP eQTLs that predict the expression of a
transcript (Table S1 lists these CNVs based on the number of SNP
eQTLs within); these CNVs show an average SNP eQTL density
of 6 per 10 kb.
We observed 1,306 CNVs (out of the 3,432 CNVs included in
the WTCCC study) containing at least one SNP eQTL. Notably,
CNVs that harbor a greater number of SNP eQTLs tend to be less
well-tagged; this observation holds robustly after accounting for
CNV minor allele frequency, which shows little correlation with
the number of SNP eQTLs within the CNV (corr=0.005). In
particular, of the top 100 WTCCC CNVs ranked according to the
number of SNP eQTLs within, only 31 are well-tagged (r
2$0.80)
and 56 are tagged at r
2,0.30.
SCAN: SNP and CNV annotation as eQTLs
Given the observed functional relevance of tCNVs as regulatory
polymorphisms, we comprehensively and systematically charac-
terized the recent genome-wide survey of CNVs in HapMap
lymphoblastoid cell lines (LCLs) for their role in expression. We
expanded our SCAN database [12], which to date serves results
only on expression associated SNPs, to include eQTL mappings of
HapMap CNVs to transcriptional expression (assayed by the
Affymetrix exon array) in the full set of HapMap CEU
(Caucasians from UT, USA) and YRI (Yoruba people from
Ibadan, Nigeria) populations (See Materials and Methods). This
online catalog of expression associated CNVs (eCNVs), publicly
available at http://www.scandb.org, should serve as an important
resource in helping to inform our understanding of complex traits.
Figure 1. SNPs tagging tCNVs are likely to be eQTLs. (A) SNPs tagging tCNVs (r
2$0.80) are enriched for cis-acting eQTLs (eQTLs within 4 mb of
target transcript). The distribution of the number of cis-acting eQTLs (at p,10
24) in 1,000 draws (each of same count as the number of tCNVs) of
frequency-matched variants is shown in the bar graphs, with the actual number of cis-acting eQTLs observed in the tCNVs from the Wellcome Trust
study shown as a solid circle. (B) SNPs tagging tCNVs are more likely to be eQTLs that predict the transcript levels of 10 or more genes than
frequency-matched variants.
doi:10.1371/journal.pgen.1001292.g001
CNVs As Trait-Associated Variants and As eQTLs
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transcript (at p value threshold of 10
24) in the CEU and YRI
samples, 31.1% and 33.1% respectively are predicting the
expression of 5 or more transcripts. This is a much higher
proportion than is the case for the well-tagged CNVs in the
WTCCC CNV study (12.8%).
Reproducible trait associations are enriched for tCNVs
Among trait-associated SNPs as represented in the NHGRI
catalog, we found a significant overrepresentation (p=0.01) for
tCNVs (r
2$0.80). Figure 2 shows the distribution of the number of
tag SNPs generated from 1000 random sets of SNPs matching the
minor allele frequency of the trait-associated SNPs. Table 2 shows
the observed overlap between the trait-associated SNPs and the
tCNVs (r
2$0.80). Enrichment analysis of disease classes shows that
the observed tCNV enrichment for reproducible trait associations
holds for autoimmune disorders and in quantitative metabolic
traits.
Three HLA region CNVs, namely CNVR2841.20, CNVR2845.14,
and CNVR2845.46, were recently shown to be associated with
Crohn’s disease, rheumatoid arthritis, and type 1diabetes, respec-
tively [8]. Our expression study confirms that the last two of these
(tagged at r
2.0.90) are eQTLs that regulate the expression of
multiple genes in this region; in contrast, the first CNV shows no
evidence for being an eQTL. A previously identified Crohn’s disease
associated locus CNVR2647.1 [5] on chromosome5, 22 kbupstream
of the IRGM gene, is a trans eQTL for SHISA4 (p=3e-05). Two
replicated SNPs associated with HDL cholesterol are tagging
(r
2$0.99) nearby CNVs, CNVR3814.1 (chrom8:19898924–
19899800) and CNVR5165.1 (chrom11:48557432–48560877). Our
study shows that both CNVs are eQTLs, with CNVR5165.1
targeting, distally, the olfactory receptor gene OR6J1. The CNV
CNVR3814.1 is also well-tagged (r
2=0.913) by a SNP reproducibly
associated with triglycerides and is an eQTL targeting ARF4, which
has been shown, in mice, to be involved in metabolic disorders [13].
Discussion
Some studies have observed a differential taggability for
common CNVs; these loci, it is argued, are less likely to be in
strong LD (r
2.0.8) with flanking markers than are frequency-
matched SNPs. Several explanations have been proposed to
account for this observed differential taggability, such as lower
SNP density in regions near CNVs and the higher mutation rates
of certain CNVs (producing greater allelic diversity nearby) than
those of SNPs [2,14,15]. This observed difference in the
magnitude of LD between CNVs and SNPs relative to LD among
SNPs impacts, through its effect on allelic association, our ability
to assess the phenotypic influence of CNVs. On the other side of
this controversy, the recent genome-wide study of an extensive
catalog of CNVs in 16,000 cases of eight common diseases has
argued that CNVs are generally well-tagged by SNPs. Indeed,
among 2- and 3- class CNVs that passed QC and had
MAF.10%, the study found that nearly 80% were tagged by
SNPs at r
2.0.80. Consequently, replication of association results
for CNVs can be conducted in an independent sample set by the
use of tag SNPs. In this study, we set out to conduct a study of
CNVs by analyzing their effect on gene expression and their
Figure 2. Trait-associated SNPs are significantly enriched for SNPs tagging tCNVs. The distribution of the number of SNPs tagging tCNVs
in 1,000 draws of SNPs from bins matched for minor allele frequency to the trait-associated SNPs is shown in the bar graphs.
doi:10.1371/journal.pgen.1001292.g002
CNVs As Trait-Associated Variants and As eQTLs
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that are well-tagged by SNPs, which we call tCNVs, facilitate
SNP-based simulation studies to evaluate enrichment. We
proceeded to test whether these CNVs were disproportionately
more likely to be functional than frequency-matched SNPs, as
trait-associated loci or, under the assumption that few trait-
associated polymorphisms are likely to alter the composition of
gene products, as eQTLs influencing phenotype by altering gene
regulation. Our study found that CNV-tagging SNPs are enriched
for cis eQTLs, and, furthermore, that reproducible trait associa-
tions show an overrepresentation of tCNVs relative to frequency-
matched SNPs. While the tagged CNVs are particularly easy to
investigate in enrichment studies, we found that the proportion of
eQTLs (at p value threshold of 10
24) in the non-WTCCC CNVs
(39%) is higher than in the well-tagged WTCCC CNVs (30%).
Given these strong findings on the functional relevance of CNVs,
we created a comprehensive online resource of expression
associated CNVs in the HapMap populations to supplement our
earlier studies on SNP eQTLs.
CNVs can affect phenotype in several ways [16]. Genes fully
covered by CNVs may contribute to disease through a
duplication or deletion event. Copy number variant breakpoints
may disrupt the expression of genes that overlap CNVs. On the
other hand, we have identified two CNVs at considerable
distance (in trans) from their targets controlling transcript
abundance as potential master regulators. Another CNV contains
multiple regulatory elements which are each predicting the
expression of at least 80 transcripts; the deletion of such
important regulatory elements is likely to profoundly alter gene
transcription. Importantly, we observed that 1,306 CNVs (out of
the 3,432 CNVs included in the WTCCC study) harbor at least
one SNP eQTL (defined at p value threshold of 10
24). Given our
earlier observation that tCNVs are enriched for expression-
associated CNVs (eCNVs), it is interesting to ask whether those
CNVs not well-tagged by SNPs have interesting properties with
respect to gene regulation. Of the CNVs that are tagged at
r
2,0.30, 44% harbor SNP eQTLs.
Previous studies [7,15,16] have reported that genes that
undergo dosage differences due to the presence (proximity) of
CNVs show an enrichment for genes involved in immune response
and response to external biotic stimuli. We identified an olfactory
receptor gene OR6J1 and a gene DAD1 (defender against cell
death 1), both on chromosome 14, that are trans-regulated genes
for the tCNV CNVR5165.1 on chromosome 11. We found an
overrepresentation for target genes involved in the calibrated
molecular response to stimulus (whether chemical stimulus or
potential internal or invasive threat). Our novel observation in this
regard is that previously reported enrichment for genes relevant
for molecular-environmental interactions generalizes to the target
genes for tCNVs as eCNVs.
The recent WTCCC CNV study concluded that common
CNVs that can be typed on existing platforms are unlikely to have
a major role in the genetic basis of complex diseases [8]. The same
study reported that there was no enrichment of association signals
among CNVs involving exonic deletions. Our findings recom-
mend caution in assessments of the contribution of CNVs to the
genetics of complex traits. Even under the assumption that most
common CNVs are well tagged by SNPs and therefore
interrogated by existing SNP GWAS, reproducible trait associa-
tions are enriched for these CNVs compared to random
expectation. The prominence of such CNVs among reproducible
trait associations with autoimmune disorders and metabolic traits
suggests that these variants may indeed contribute to certain
disease classes; alternatively, they may act in conjunction with
other variants such as SNPs to confer susceptibility. Importantly,
these CNVs are disproportionately more likely to predict
transcript levels than frequency-matched SNPs, and they are
more likely to affect many different gene expression traits as
master regulatory polymorphisms. An important issue to address is
whether the enrichment of tCNVs as eQTLs and as disease-
Table 2. The observed overlap between the NHGRI SNPs and SNPs tagging CNVs (r
2$0.80).







rs11576866 1 10337019 rs10492972 0.887 CNVR65.1(0.98) Multiple sclerosis
rs12191877 6 31360904 rs10484554 1 CNVR2841.6(0.90) Psoriasis, AIDS progression
rs1450111 3 157567524 rs3772255 0.948 CNVR1591.1(1) Aging traits
rs2001114 6 167406568 rs2301436 0.814 CNVR3164.1(1) Crohn’s Disease
rs2410618 8 19897780 rs2083637 1 CNVR3814.1(0.998) Waist circumference and
related phenotypes, HDL
cholesterol
rs36149991 6 32630367 rs3135388 1 CNVR2845.46(0.94) Multiple sclerosis
rs6693105 1 150857287 rs4085613 1 CNVR358.1(0.956) Psoriasis
rs7560547 2 203466161 rs6725887 1 CNVR1111.1(1) Myocardial Infarction (early
onset)
rs9635398 15 84147059 rs7176093 0.846 CNVR6495.1(1) Aging traits
rs4882017 11 48526758 rs7395662 1 CNVR5165.1(1) HDL cholesterol
rs4529687 1 87386671 rs7553864 1 CNVR240.1(0.99) Smoking behavior
rs11249248 1 25625638 rs10903129 0.967 CNVR117.1(0.945) Cholesterol, total
rs11209948 1 72584492 rs2568958 1 CNVR217.1(1) Body mass index
rs9405040 6 32547371 rs2395185 1 CNVR2845.14(0.90) Ulcerative colitis
rs1384601 12 33606133 rs9300212 0.99 CNVR5492.1(0.997) Cognitive
doi:10.1371/journal.pgen.1001292.t002
CNVs As Trait-Associated Variants and As eQTLs
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random SNP is found in the NHGRI catalog increases from
0.062% in the set of HapMap SNPs to about 0.5% (more than 5-
fold) in the set of well-tagged CNVs that are not eQTLs and to 2%
in the tCNVs that are eQTLs.
It should be noted that the WTCCC CNVs included in our
study reflect certain limitations. Indeed, as the WTCCC study
itself explicitly noted [8], a large proportion (nearly 60%) of the
candidate list of putative CNVs could not be reliably assigned copy
number classes from the combination of experimental assay and
analytical approaches; it is estimated that only about half of these
are not polymorphic [8]. Particularly, nearly 6,500 such putative
polymorphisms were excluded from subsequent analyses, as they
were called with a single copy number class. It is of course possible
that our conclusions may not generalize to these CNVs.
Furthermore, eQTL mapping in microarray-based studies in
LCLs is likely to yield only a subset of the eQTLs that will be
identified using more refined methods in a variety of human
tissues. The present study also has little conclusive to say about low
frequency variants. Despite these current limitations, the annota-
tion system we implemented in SCAN should prove useful to other
investigators and seeks to be as comprehensive as possible by
providing functional information for the most extensive map of
CNVs to date from the recent population-based genome-wide
survey [7]. Since the MAF spectrum of the NHGRI catalog of
trait-associated SNPs from published GWAS is quite different
from that of the SNPs on the genotyping platforms used to conduct
these GWAS, we performed our enrichment analyses while
conditioning on the MAF distribution. There are other potential
representational biases in the NHGRI catalog of reported variants
that may have affected our studies. The enrichment in disease
classes relative to other classes of traits, for example, may be the
result of increased power (e.g., due to greater sample sizes) for
these categories.
Since gene expression is intermediate to other complex
phenotypes, a global view of the influence of CNVs on the
transcriptome may lead to a better understanding of their role in
disease susceptibility. While we identified, as perhaps expected,
CNVs located in the HLA region associated with multiple
expression phenotypes and with various autoimmune disorders,
we also observed, strikingly, several non-HLA CNVs that regulate
multiple transcripts, including 2 (one on chromosome 10 and the
other on chromosome 2) associated with more than 100 expression
traits. Using the most extensive population-based CNV map
available [7], we observed a greater proportion of master
regulatory CNVs than observed among the well-tagged CNVs.
Collectively, all these findings reinforce the importance of
considering all types of variation to elucidate the genetic
architecture of complex traits.
Materials and Methods
Gene expression dataset using Affymetrix Exon Array
The mRNA expression was assayed in HapMap lymphoblastoid
cell lines (LCLs) in 87 CEU and 89 YRI using the Affymetrix
GeneChip Human Exon 1.0 ST Array [18]. This dataset is
available in the public repository Gene Expression Omnibus
(Accession No: GSE9703). Measurements on the exon array are
done both at the exon-level and at the gene-level. The exon array
includes 1.4 million probesets and profiles nearly 13,000 transcript
clusters. The transcript clusters include a set of probesets
containing all known exons and 59 and 39 UTR regions in the
genome so that probes interrogate entire gene regions and not just
39 UTRs (in contrast to other arrays).
SCAN: A database of eQTL SNPs and CNVs
The results of our eQTL studies, previously on single base
polymorphisms [10,17,18], in HapMap LCLs have been made
publicly available in an online database SCAN [12]. To evaluate
the influence of CNVs on the transcriptome, we performed linear
regression on over 13,000 transcript clusters with reliable
expression – namely, the log2 transformed normalized expression
intensity is greater than 6 for at least 80% of the samples – and the
CNVs assayed in HapMap LCLs. We downloaded genotype
information for these CNVs from the recently released reference
catalog of HapMap CNVs [7]. All eQTL analyses were done in
both CEU and YRI samples. We extended the SCAN database to
include a catalog of expression-associated CNVs in the HapMap
populations.
NHGRI database of trait-associated SNPs
The National Human Genome Research Institute (NHGRI)
curates the results of published GWAS and makes them publicly
available in an online catalog of SNP-trait associations. This
catalog provides a useful resource for the investigation of genomic
characteristics of trait-associated SNPs and of the role of common
variants in common disease etiology [9]. The version we utilized
for our present study was retrieved on June 29, 2009. SNP-trait
associations included in the catalog are those with p val-
ues,1.0610
25, and generally only one SNP within a gene or a
high LD region is included unless there is evidence of an
independent association. To evaluate whether our observation on
the significant enrichment among tagged CNVs for trait-
associated SNPs is driven by certain traits or disease classes, we
considered separately various disease types, including neuropsy-
chiatric disorders, cancers, and autoimmune disorders.
Simulation studies
We conducted simulations to evaluate enrichment for eQTLs
among the tCNVs included in our study. To empirically generate
the null distribution of no enrichment, we randomly generated sets
of SNPs of matching minor allele frequency as the original list of
SNPs tagging the tCNVs, as previously described [10]. To enable
us to perform simulations conditional on MAF, we constructed
non-overlapping MAF bins, each of width 0.05, using the MAFs of
the SNPs in the HapMap CEU samples. The null sets were drawn
from the combined platform SNPs (Affymetrix 6.0 and Illumina
1M) as well as from the entire set of HapMap CEU SNPs. The
observed count is then compared to the empirically generated
distribution to get an empirical p value for the enrichment.
A catalog of Wellcome Trust CNVs
A survey of 3,432 WTCCC CNVs [8] shows that their minor
allele frequency distribution differs markedly from the distribution
of reproducible trait-associated SNPs as represented in the
NGHRI catalog (See Figure S2). Of these, nearly 80% with
minor allele frequency at least 10% are well tagged (r
2$0.8).
Roughly 89% of the tagged CNVs (r
2$0.8) are less than 10 kb in
length, and 26% are less than 1 kb long (See Figure S3). Table S2
shows the median length (in log10) of the WTCCC CNVs.
The 3,432 CNVs included in this study passed the WTCCC
quality control filters out of the 4,326 that were called with
multiple classes [8].
Supporting Information
Figure S1 (A) SNPs perfectly tagging CNVs (i.e., r2=1.0) are
enriched for eQTLs that regulate transcript levels in cis. The
distribution of the number of cis-acting eQTLs (at p,1024) in
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frequency-matched SNPs is shown in the bar graphs, with the
actual number of eQTLs observed in the tCNVs from the
Wellcome Trust study shown as a solid circle. (B) SNPs perfectly
tagging CNVs (i.e., r2=1.0) are more likely to be eQTLs that
predict the transcript levels of 10 or more genes than frequency-
matched SNPs.
Found at: doi:10.1371/journal.pgen.1001292.s001 (3.62 MB TIF)
Figure S2 The minor allele frequency distribution of the CNVs
from the WTCCC survey is shown. Their minor allele frequency
distribution differs markedly from the distribution of reproducible
trait-associated SNPs from the NHGRI catalog.
Found at: doi:10.1371/journal.pgen.1001292.s002 (1.35 MB TIF)
Figure S3 The size distribution of the CNVs from the WTCCC
study is shown. CNV length ranges from 0.446 kb to 662 kb with
average 14 kb.
Found at: doi:10.1371/journal.pgen.1001292.s003 (1.22 MB TIF)
Table S1 We identified 33 CNVs harboring 50 or more SNP
eQTLs that predict the expression of a transcript.
Found at: doi:10.1371/journal.pgen.1001292.s004 (0.02 MB
XLS)
Table S2 The length of the different categories of CNVs
evaluated in our study.
Found at: doi:10.1371/journal.pgen.1001292.s005 (0.02 MB
XLS)
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